Correction to: Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO)

Hui Shao, Vivian Fonseca, Charles Stoecker, Shuqian Liu and Lizheng Shi ()
Additional contact information
Hui Shao: Tulane University
Vivian Fonseca: Tulane University
Shuqian Liu: Tulane University
Lizheng Shi: Tulane University

PharmacoEconomics, 2019, vol. 37, issue 8, No 9, 1069-1069

Abstract: The original article can be found online.

Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-019-00807-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:37:y:2019:i:8:d:10.1007_s40273-019-00807-3

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-019-00807-3

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().